Over the past three decades, an increasing trend in the burden of AD has been observed globally. 3 The rapid increase in the prevalence and societal and economic burden of AD has prompted an urgent need for efficient intervention and treatment for AD. 4 However, AD treatment remains challenging.
← all excerpts
Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease.
1
—
—